Previous 10 | Next 10 |
Evofem Biosciences (EVFM) -43% on planned public offering. Ross Stores (ROST) -23% on Q1 results. Bright Green (BGXX) -12%. NeuroMetrix (NURO) -10%. Burlington Stores (BURL) -10%. Novan, Inc. (NOVN) -8%. Upstart Holdings (UPST) -7% Saxena White P.A. files new securiti...
– Based on clinical data from previously completed B-SIMPLE4 pivotal Phase 3 clinical study, berdazimer gel, 10.3% (SB206) can shorten the duration of molluscum infection and increase the chance of clearance by enhancing inflammation of molluscum – – Current...
Novan, Inc. (NOVN) Q1 2022 Earnings Conference Call May 16, 2022, 8:30 AM ET Company Participants Paula Brown Stafford - Chairman, President and Chief Executive Officer John Donofrio - Chief Operating Officer, Novan and President, EPI Health John Gay - Chief Financial Officer Conference Call ...
Novan press release (NASDAQ:NOVN): Q1 GAAP EPS of -$0.71. Revenue of $1.9M (+137.5% Y/Y). As of March 31, 2022, Novan had a total cash and cash equivalents balance of $35.5 million. For further details see: Novan GAAP EPS of -$0.71, revenue of $1.9M
– Transformational quarter for Novan, marked by acquisition of EPI Health – – Strongest quarter in total prescriptions for Rhofade increasing 47% from Q1 2021 – – Ongoing activities toward submission of first New Drug Application (NDA) ...
Novan (NASDAQ:NOVN) is scheduled to announce Q1 earnings results on Monday, May 16th, before market open. The consensus EPS Estimate is -$0.51 (-750.0% Y/Y) and the consensus Revenue Estimate is $1.35M (+64.6% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 down...
BITF, CGEN, CLSN, CMRX, OTCQB:CVSI, GOED, KALA, LTRY, LUNA, MNMD, NOVN, OEG, PLX, PTE, SOHU, SSYS, SYN, SYRS, TCRT, WEJO, WIX, WRBY For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open
DURHAM, N.C., May 06, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its first quarter 2022 financial results on Monday, May 16 th . Novan management will host a conference call and live aud...
Gainers: Vallon Pharmaceuticals (VLON) +84%. Shattuck Labs (STTK) +12%. Establishment Labs (ESTA) +11%. INVO Bioscience (INVO) +5%. Novan (NOVN) +5%. Losers: Babylon Holdings (BBLN) -41%. SCYNEXIS (SCYX) -25%. Clarus Therapeutics (CRXT) -16%. HCA H...
DURHAM, N.C., April 20, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced it will participate in the Virtual Investor Innovation in Dermatology Spotlight event on Tuesday, April 26, 2022, at 2:00 PM ET. For the ...
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...